Blue Earth Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BLUE EARTH, and when can generic versions of BLUE EARTH drugs launch?
BLUE EARTH has one approved drug.
There are seven US patents protecting BLUE EARTH drugs.
There are twenty-seven patent family members on BLUE EARTH drugs in sixteen countries.
Drugs and US Patents for Blue Earth
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Blue Earth | AXUMIN | fluciclovine f-18 | SOLUTION;INTRAVENOUS | 208054-001 | May 27, 2016 | RX | Yes | Yes | 10,953,112 | See Plans and Pricing | See Plans and Pricing | ||||
Blue Earth | AXUMIN | fluciclovine f-18 | SOLUTION;INTRAVENOUS | 208054-001 | May 27, 2016 | RX | Yes | Yes | 10,124,079 | See Plans and Pricing | See Plans and Pricing | ||||
Blue Earth | AXUMIN | fluciclovine f-18 | SOLUTION;INTRAVENOUS | 208054-001 | May 27, 2016 | RX | Yes | Yes | 10,716,868 | See Plans and Pricing | See Plans and Pricing | ||||
Blue Earth | AXUMIN | fluciclovine f-18 | SOLUTION;INTRAVENOUS | 208054-001 | May 27, 2016 | RX | Yes | Yes | 10,933,147 | See Plans and Pricing | See Plans and Pricing | ||||
Blue Earth | AXUMIN | fluciclovine f-18 | SOLUTION;INTRAVENOUS | 208054-001 | May 27, 2016 | RX | Yes | Yes | 10,967,077 | See Plans and Pricing | See Plans and Pricing | ||||
Blue Earth | AXUMIN | fluciclovine f-18 | SOLUTION;INTRAVENOUS | 208054-001 | May 27, 2016 | RX | Yes | Yes | 9,387,266 | See Plans and Pricing | See Plans and Pricing | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Blue Earth
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Blue Earth | AXUMIN | fluciclovine f-18 | SOLUTION;INTRAVENOUS | 208054-001 | May 27, 2016 | 5,808,146 | See Plans and Pricing |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Blue Earth Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Norway | 20082877 | See Plans and Pricing |
European Patent Office | 1978015 | See Plans and Pricing |
Japan | 5684333 | See Plans and Pricing |
Australia | 2006319987 | See Plans and Pricing |
Brazil | PI0619213 | See Plans and Pricing |
Israel | 235029 | See Plans and Pricing |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.